Daily Washington Insider
  • Business
  • World
  • Science
  • Investing

Daily Washington Insider

  • Business
  • World
  • Science
  • Investing
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

Keith Weiner: All Roads Lead to Gold Right...

March 27, 2025

Rob McEwen: Gold to Hit US$5,000 Long Term,...

March 18, 2025

Rio Tinto and Sumitomo Partner to Advance Winu...

December 6, 2024

1911 GOLD ANNOUNCES OUTCOME OF TSX VENTURE EXCHANGE...

November 6, 2025

Cardiol Therapeutics’ Phase II ARCHER Trial Results to...

November 5, 2025

Two Water Wells Completed & Staking Finalised at...

January 30, 2025

West High Yield

April 13, 2024

Dana Samuelson: Gold, Silver in Global Bank Run,...

November 15, 2025

Silver Price Surges to US$36, Marking 13 Year...

June 6, 2025

Crypto Market Update: Trump Orders 401(k) Crypto Review,...

August 11, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Hong Kong plans to install thousands of surveillance cameras. Critics say it’s...

    • 2

      UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’

    • 3

      Trump has assembled a team of China hawks. How will Beijing respond?

    • 4

      China executes man who plowed car into crowds in deadliest attack in a decade

    • 5

      How Calvin Klein and Tommy Hilfiger got caught in Trump’s trade war with China

    Categories

    • Business (1,370)
    • Investing (4,114)
    • Science (605)
    • World (3,677)
    Footer Logo

    Disclaimer: dailywashingtoninsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 dailywashingtoninsider.com | All Rights Reserved